癌症预防的代价:降低风险性全胃切除术的躯体与心理社会后遗症
该单机构自然史研究纳入126例携带致病或可能致病种系CDH1变异、于2017年10月至2021年12月接受降低风险性全胃切除术的个体,评估急慢性手术并发症与健康相关生活质量。术后30天内严重并发症发生率为5.6%(7/126),98.4%的患者体重下降,术后2年94%(64/68)存在至少一种慢性并发症,部分患者出现职业改变(23.5%)、离婚(3%)和酒精依赖(1.5%)。作者认为咨询CDH1变异携带者时应讨论这些改变生活的后果。
要点
- 126例CDH1变异携带者接受降低风险性全胃切除术,87.3%(110/126)术后病理为pT1aN0伴印戒细胞特征胃癌。
- 术后30天内严重并发症发生率5.6%(7/126),98.4%的患者全胃切除后体重下降。
- 术后2年94%(64/68)存在至少一种慢性并发症,包括胆汁反流、吞咽困难和微量营养素缺乏。
核心结论
- 降低风险性全胃切除术与改变生活的严重不良事件相关,在向CDH1变异携带者咨询胃癌预防时应讨论这些事件。
- 癌症预防手术的风险不仅应基于未经治疗时死于疾病的可能来评判,还应基于器官切除的真实后果来评判。
研究设计与样本
- 单机构遗传性胃癌自然史研究,纳入2017年10月至2021年12月因致病或可能致病种系CDH1变异接受降低风险性全胃切除术的126例个体。
- 评估临床病理细节、急性和慢性手术并发症及健康相关生活质量,使用验证问卷测定生活质量评分与心理社会精神愈合指标。
主要发现
- 87.3%(110/126)的患者最终病理为pT1aN0伴印戒细胞特征的胃癌。
- 术后30天内严重并发症发生率为5.6%(7/126),98.4%的患者全胃切除后体重下降。
- 术后2年,94%(64/68)的患者出现至少一种慢性并发症(即胆汁反流、吞咽困难和微量营养素缺乏)。
- 部分患者将职业改变(23.5%)、离婚(3%)和酒精依赖(1.5%)归因于全胃切除术的改变生活后果。
- 中位随访24个月的患者中,生活质量评分在术后1个月下降,并在6至12个月恢复到基线。
临床怎么用
- 作者认为,向CDH1变异携带者咨询胃癌预防时,应讨论降低风险性全胃切除术相关的改变生活的严重不良事件。
- 作者认为,癌症预防手术的风险评判不仅应基于未经治疗时死于疾病的可能,还应基于器官切除的真实后果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Risk-reducing surgery for cancer prevention in solid tumors is a pressing clinical topic because of the increasing availability of germline genetic testing. We examined the short- and long-term outcomes of risk-reducing total gastrectomy (RRTG) and its lesser-known impacts on health-related quality of life (QOL) in individuals with hereditary diffuse gastric cancer syndrome. METHODS: Individuals who underwent RRTG as part of a single-institution natural history study of hereditary gastric cancers were examined. Clinicopathologic details, acute and chronic operative morbidity, and health-related QOL were assessed. Validated questionnaires were used to determine QOL scores and psycho-social-spiritual measures of healing. RESULTS: One hundred twenty-six individuals underwent RRTG because of a pathogenic or likely pathogenic germline CDH1 variant between October 2017 and December 2021. Most patients (87.3%; 110/126) had pT1aN0 gastric carcinoma with signet ring cell features on final pathology. Acute (<30 days) postoperative major morbidity was low (5.6%; 7/126) and nearly all patients (98.4%) lost weight after total gastrectomy. At 2 years after gastrectomy, 94% (64/68) of patients exhibited at least one chronic complication (ie, bile reflux, dysphagia, and micronutrient deficiency). Occupation change (23.5%), divorce (3%), and alcohol dependence (1.5%) were life-altering consequences attributed to total gastrectomy by some patients. In patients with a median follow-up of 24 months, QOL scores decreased at 1 month after gastrectomy and returned to baseline by 6-12 months. CONCLUSION: RRTG is associated with life-changing adverse events that should be discussed when counseling patients with CDH1 variants about gastric cancer prevention. The risks of cancer-prevention surgery should not only be judged in the context of likelihood of death due to disease if left untreated, but also based on the real consequences of organ removal.
引用
- Gallanis AF, Gamble LA, Samaranayake SG, et al. Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy. J Clin Oncol. 2023. PMID: 37903316. doi:10.1200/JCO.23.01238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。